Pharmacokinetics and Safety of AmBisome and DKF-5122

NCT05749380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Fungal Infections
Neutropenic Fever

Interventions

DRUG: AmBisome
DRUG: DKF-5122

Sponsor

Dongkook Pharmaceutical Co., Ltd.